- Home
- IRON vs HDL Comparison
IRON vs HDL Comparison
Compare IRON & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- HDL
- Stock Information
- Founded
- IRON 2017
- HDL 2016
- Country
- IRON United States
- HDL Singapore
- Employees
- IRON N/A
- HDL N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- HDL Restaurants
- Sector
- IRON Health Care
- HDL Consumer Discretionary
- Exchange
- IRON Nasdaq
- HDL Nasdaq
- Market Cap
- IRON 1.4B
- HDL 1.6B
- IPO Year
- IRON N/A
- HDL 2024
- Fundamental
- Price
- IRON $46.68
- HDL $20.44
- Analyst Decision
- IRON Strong Buy
- HDL
- Analyst Count
- IRON 9
- HDL 0
- Target Price
- IRON $93.89
- HDL N/A
- AVG Volume (30 Days)
- IRON 354.8K
- HDL 1.4K
- Earning Date
- IRON 05-07-2025
- HDL 05-21-2025
- Dividend Yield
- IRON N/A
- HDL N/A
- EPS Growth
- IRON N/A
- HDL 110.82
- EPS
- IRON N/A
- HDL 0.06
- Revenue
- IRON N/A
- HDL $789,766,000.00
- Revenue This Year
- IRON N/A
- HDL $17.95
- Revenue Next Year
- IRON N/A
- HDL $13.32
- P/E Ratio
- IRON N/A
- HDL $34.83
- Revenue Growth
- IRON N/A
- HDL 10.91
- 52 Week Low
- IRON $30.82
- HDL $13.94
- 52 Week High
- IRON $68.73
- HDL $30.00
- Technical
- Relative Strength Index (RSI)
- IRON 49.90
- HDL N/A
- Support Level
- IRON $44.85
- HDL N/A
- Resistance Level
- IRON $47.36
- HDL N/A
- Average True Range (ATR)
- IRON 2.23
- HDL 0.00
- MACD
- IRON -0.12
- HDL 0.00
- Stochastic Oscillator
- IRON 37.58
- HDL 0.00
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan.